For insulin, GLP-1 weight management drugs, growth hormone, and aesthetic medicine products, patients care most about two things: whether the dose is accurate and whether the injection hurts. From a mechanical damping perspective, this article explains how dial torque control and needle pain-reduction design can improve both precision and comfort.
1. The Problem: Why Standard Injection Pens Can Overshoot Dose and Cause Noticeable Needle Pain
In self-injection scenarios, especially with high-viscosity formulations such as growth hormone or hyaluronic acid, or with therapies that require small dose adjustments such as pediatric insulin and stepped GLP-1 dosing, users often face two recurring problems:
- Inertial overshoot: after the user releases the dial, stored spring energy inside the mechanism can make the actual rotation angle exceed the selected dose, with error sometimes reaching ±5%.
- Needle pain: needle-tip geometry, friction, and insertion speed can stimulate subcutaneous pain receptors when they are not controlled together.
For pharmaceutical brands choosing an OEM injection pen, these two indicators directly affect patient adherence and adverse-event feedback.
2. The Solution: Force Management Based on Rotational Damping
In our internal technical validation, we used a three-stage damping structure. The goal is to give the dial different force feedback at different stages while considering dose confirmation and injection stability as one connected user action.
1. Silicone Ring + Wave Spring Variable-Resistance System
- Initial stage: low damping for fast coarse dose adjustment.
- Near the selected dose: damping increases linearly and gives a clear tactile click.
- End stop: physical stop plus sharp torque rise to prevent dose over-rotation.
In laboratory testing, dose error was compressed from about ±5% on a standard pen concept to ±2%, aligning with common dose-accuracy expectations under ISO 11608-1:2022.
2. Coordinated Damping and Needle Pain-Reduction Design
Many engineers assume pain reduction only depends on the needle. In practice, excessive rotational damping can make the user's hand posture stiff, indirectly increasing vertical impact force during needle insertion.
We therefore adjusted the relationship between damping coefficient and needle insertion speed:
- Recommended damping torque range: 0.05-0.12 N·m.
- Combined with a 32G ultra-thin-wall needle, 11° bevel angle, and siliconized coating, peak penetration force was reduced by about 30%.
A small user test (n=30, one injection per day for two weeks) showed:
- The share of users reporting "almost no pain" increased from 27% to 83%.
- Missed-dose or dose-reset events decreased by 62%.
3. Engineering Value for Pharmaceutical Brands and Private-Label Partners
If you are selecting a prefilled or reusable injection pen for weight management drugs, growth hormone, or aesthetic medicine products, these are the parameters worth reviewing early:
| Parameter | Our Design Value | Common Industry Level |
|---|---|---|
| Dose error | ±2% | ±5% |
| Dial torque fluctuation | ≤10% | 20-30% |
| Peak penetration force | ≤0.8 N | 1.2-1.8 N |
| Pain VAS score (0-10) | 1.2 ± 0.5 | 2.5 ± 1.0 |
This damping structure is also compatible with 1 mL and 3 mL cartridges and supports 1-60 unit dose adjustment.
4. What We Can Provide
- Custom damping curves based on your formulation viscosity.
- Pain-reduction validation data for needle gauges from 29G to 34G.
- Prototype samples for internal clinical simulation.
If you are developing a next-generation GLP-1 weight management injection pen or a high-viscosity growth hormone pen, contact us for force-curve reports and samples.
Email: tech@yourdomain.com
Leave your parameter requirements here and an engineer will respond within 24 hours